Valuation
- Market cap
- 35,272,000
- Revenue TTM
- $0
- Net income TTM
- $-71,150,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 163,453
- Avg volume
- 579,358
- Day's range
- $1.11 – $1.18
- Shares out
- 30,407,000
- Stochastic %K
- 21%
- Beta
- 0.17
- Analysts
- Strong Buy
- Price target
- —
Company profile
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 858 369 7100
- Website
- https://www.litestrategy.com
- Address
- 9920 Pacific Heights Blvd., Suite 150, San Diego, United States
Latest news
No headlines yet.
